Daniel Oliver: Building a "Facebook" for investments in biotech startups

© CompassList

The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide

Founded in 2015, Capital Cell was the first European platform for equity crowdfunding in biotechnology and health startups. With nearly €15m in investments from 35 funding rounds, the company today counts 7,000 registered investors, making it one of Spain’s biggest health-tech private investment networks.Capital Cell CEO and founder Daniel Oliver believes that one of the fundamental problems for biotech companies is access to funding but for investors putting their money into biotech and health solutions, it is not the same as investing in SaaS or e-commerce. It requires know-how that man...
Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.